Masataka Suzuki

8PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Electrical machines and drivesHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 09, 2024
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity.

Daisuke Morita, Amanda Rosewell Shaw, Greyson Biegert

|Sep 03, 2024
Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors.

Allison J Nipper, Emilie A K Warren, Kershena S Liao

|Mar 17, 2024
Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cells.

Jonas Kath, Clemens Franke, Vanessa Drosdek

|Dec 20, 2023
Integration of ζ-deficient CARs into the CD3-zeta gene conveys potent cytotoxicity in T and NK cells.

Jonas Kath, Clemens Franke, Vanessa Drosdek

|Dec 15, 2023
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Sunny Mai, Alan Hodges, Hui-Ming Chen

|Mar 29, 2023
Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies.

Daniel Wang, Caroline E Porter, Bora Lim

Pageof 2

Frequent Collaborators

3 joint publications

Caroline Porter

2 joint publications

Amanda Rosewell Shaw

2 joint publications

Greyson G W Biegert

2 joint publications

Viktor Glaser